|
|
 |
|
Viewing report
|
|
|
Aastrom Biosciences Inc (09-Jan-2012)
Directors Deals Ltd, Jan 2012, Pages: 1
Scott Durbin, (PDMR) Chief Financial Officer of Aastrom Biosciences Inc [market cap £46million] sold 40,000 shares at 1.800USD, holding is now 850 shares; representing 0.002 percent of the shares on issue. Holding has decreased 98 percent, the total trade value was £46,216 and the significance rating is 69/100.
Directors Deals monitors and analyses share transactions made by directors in the shares of their own company. We monitor 18,000 companies share transactions in 46 countries worldwide (32 in Europe, 7 in Asia, 2 in North America, 2 in Oceania, 2 in the Middle East & 2 in Africa).
|
|
|
|
